A Clinical and Preclinical Assessment of Clinical Trials for Dry Age-Related Macular Degeneration

Age-related macular degeneration (AMD) is the leading cause of blindness for the elderly in high-income countries. Although multivitamin antioxidant nutrients can slow the progression of intermediate “dry” or nonneovascular AMD, no treatment can halt or reverse any stage of dry disease. Multiple bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Abidi, Muhammad, Karrer, Erik, Csaky, Karl, Handa, James T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Translational Science Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767821/
https://www.ncbi.nlm.nih.gov/pubmed/36570624
http://dx.doi.org/10.1016/j.xops.2022.100213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9767821/
https://www.ncbi.nlm.nih.gov/pubmed/36570624
http://dx.doi.org/10.1016/j.xops.2022.100213

Ejemplares similares